| Date Filed | Type | Description |
| 11/27/2019 |
GN
| Clairvest Portfolio Updates – Top Aces & Accel Entertainment |
| 01/25/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 12/29/2016 |
D/A
| Form D/A - Notice of Exempt Offering of Securities [Amend] |
| 06/11/2013 |
8-K
| Quarterly results |
| 06/11/2013 |
10-Q
| Quarterly Report for the period ended April 30, 2013 |
| 05/10/2013 |
10-Q
| Quarterly Report for the period ended April 30, 2012 |
| 05/07/2013 |
10-Q
| Quarterly Report for the period ended January 31, 2012 |
| 05/07/2013 |
10-Q
| Quarterly Report for the period ended October 31, 2012 |
| 05/07/2013 |
10-Q
| Quarterly Report for the period ended October 31, 2011 |
| 05/03/2013 |
10-Q/A
| Quarterly Report for the period ended January 31, 2013 [amend] |
| 05/03/2013 |
10-Q
| Quarterly Report for the period ended January 31, 2013 |
| 05/01/2013 |
10-Q
| Quarterly Report for the period ended April 30, 2011 |
| 04/26/2013 |
3/A
| Sulley Jamie Marie (President) has filed a Form 3/A on Tamir Biotechnology, Inc. |
| 04/25/2013 |
10-K
| Annual Report for the period ended July 31, 2012 |
| 04/25/2013 |
10-K
| Annual Report for the period ended July 31, 2011 |
| 02/26/2013 |
3
| Ostronic Francis Patrick (Director) has filed a Form 3 on Tamir Biotechnology, Inc. |
| 02/25/2013 |
3
| Barsa Joanne Marie (CFO) has filed a Form 3 on Tamir Biotechnology, Inc. |
| 02/21/2013 |
3
| Sulley Jamie Marie (President) has filed a Form 3 on Tamir Biotechnology, Inc. |
| 02/08/2013 |
SC 13D
| WEINER DAVID reports a 7.7% stake in Tamir Biotechnology, Inc. |
| 01/15/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/14/2013 |
SC 13D/A
| Knoll Capital Management, LP reports a 38.8% stake in TAMIR BIOTECHNOLOGY, INC. |
| 12/27/2012 |
D
| Form D - Notice of Exempt Offering of Securities |
| 12/26/2012 |
3
| EUROPA INTERNATIONAL INC (10% Owner) has filed a Form 3 on Tamir Biotechnology, Inc. |
| 10/19/2012 |
8-K
| Entry into a Material Definitive Agreement |
| 07/25/2012 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Tamir Biotechnology, Inc.|
Txns:
| Granted 540,000 options to buy
@ $0.04, valued at
$21.6k
|
|
| 07/25/2012 |
4
| KENYON LAWRENCE A (President, CEO and CFO) has filed a Form 4 on Tamir Biotechnology, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.04, valued at
$16k
|
|
| 07/25/2012 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Tamir Biotechnology, Inc.|
Txns:
| Granted 375,000 options to buy
@ $0.04, valued at
$15k
|
|
| 07/25/2012 |
4
| WEISS PAUL M (Director) has filed a Form 4 on Tamir Biotechnology, Inc.|
Txns:
| Granted 375,000 options to buy
@ $0.04, valued at
$15k
|
|
| 06/14/2012 |
8-K
| Form 8-K - Current report |
| 03/16/2012 |
8-K
| Form 8-K - Current report |
| 01/13/2012 |
8-K/A
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 12/23/2011 |
3
| KENYON LAWRENCE A (CEO, CFO) has filed a Form 3 on Tamir Biotechnology, Inc. |
| 12/23/2011 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/15/2011 |
8-K
| Entry into a Material Definitive Agreement |
|